# US 2015/0147313 A1 · Animal product-free culture medium for bacteria of the genus clostridium and a process for producing supernatant comprising one or more collagenolytic and gelatinolytic proteases

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0147313 A1
- Document ID: US20150147313A1
- Status: Published application
- Kind: A1
- Application number: 14/404,155
- Filed: 2013-05-29
- Published: 2015-05-28
- Earliest claimed: 2012-05-31
- Assignees: Cristalia Produtos Quimcos Farmaeuticos Ltda.
- Applicants: Cristalia Produtos Quimcos Farmaeuticos Ltda.
- Inventors: Marcos Castanheira Alegria; Lucidio Cristoväo Fardelone; Marina Baiochi Riboldi Delalana; Josef Ernst Thiemann; Spartaco Astolfi Filho; Roberto Carlos Debom Moreira; Ogari de Castro Pacheco
- Web page: https://patentgrep.com/patent/US20150147313A1

## CPC

- C12N 1/20: Bacteria; Culture media therefor
- A61K 38/4886: {Metalloendopeptidases (3.4.24), e.g. collagenase}
- A61P 19/04: for non-specific disorders of the connective tissue
- C12N 9/52: derived from bacteria {or Archaea}
- C12P 1/04: by using bacteria
- C12Y 304/24003: Microbial collagenase (3.4.24.3)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The present invention refers to a culture medium and a process for producing proteases with collagenolytic and gelatinolytic activity by bacteria of the genus Clostridium. Particularly, the present invention refers to an animal product-free culture medium for C. histolyticum, characterized by comprising non-animal origin peptones, preferably vegetable peptones, yeast extract and the amino acids cysteine and arginine. The present invention also refers to a process for producing Clostridium histolyticum liquid culture supernatant comprising one or more proteases with collagenolytic and gelatinolytic activity, and pharmaceutical composition comprising as active ingredient the supernatant or the supernatant optionality purified.

## Claims

### Claim at position 1

1-32. (canceled)

### Claim 33

An animal product-free culture medium for bacteria of the genus Clostridium comprising water, non-animal origin peptone, or its derivatives, yeast extract and the amino acids cysteine and arginine, or pharmaceutically acceptable salts thereof.

### Claim 34 (depends on 33)

The culture medium according to claim 33, wherein the non-animal origin peptone is a vegetable peptone selected from the group consisting of soy, cotton, wheat, sunflower, rice, peanuts, fava bean, peas, potato, corn and mixtures thereof.

### Claim 35 (depends on 34)

The culture medium according to claim 34, wherein the vegetable peptone is a soy peptone selected from the group consisting of Hy Soy, Soytone, Amisoy, NZ Soy BL4, NZ Soy BL7, Hy Pep 1510, Hy Pep 1511, Hy Pep 5603, Hy Pep 7504, Stedygro Soy SE50M, Proyield Soy, SE50MAF-UF, Soy peptone 312, Hy Pep 4601 and mixtures thereof.

### Claim 36 (depends on 33)

The culture medium according to claim 33, wherein the yeast extract is selected from the group consisting of Bacto YE, Hy-Pep YE, Hy-Yeast 412, Hy-Yeast 413, Hy-Yeast 502, Hy-Yeast 501, Hy-Yeast 503 Prodex 710 SD, Prodex NS70SD, Pronal 5001, YE 11, YE 151, YE 251, YE 70161, YE Y4250, Synth, YE 207, YE 5114 and mixtures thereof.

### Claim 37 (depends on 33)

The culture medium according to claim 33, wherein the bacteria is Clostridium histolyticum, the non-animal origin peptone is NZ soy BL4, the yeast extract is YE 251, the cysteine is cysteine hydrochloride and the arginine is arginine hydrochloride.

### Claim 38 (depends on 33)

The culture medium according to claim 33, wherein the concentration of non-animal origin peptone ranges from 0.5% to 5% w/v, yeast extract from 0.5% to 5% w/v, cysteine, or its pharmaceutically acceptable salts, from 0.01% to 0.1% w/v, and arginine, or its pharmaceutically acceptable salts, from 0.1% to 1% w/v.

### Claim 39 (depends on 38)

Culture medium according to claim 38, wherein the concentration of non-animal origin peptone is 3% w/v, yeast extract is 3% w/v, cysteine, or its pharmaceutically acceptable salts, is 0.0625% w/v and arginine, or its pharmaceutically acceptable salts, is 0.375% w/v.

### Claim 40 (depends on 33)

The culture medium according to claim 33, further comprising one or more additives selected from the group consisting of agent for adjustment of pH from 7 to 8, reducing agent, inorganic salts and vitamins.

### Claim 41 (depends on 40)

The culture medium according to claim 40, wherein the reducing agent is selected from the group consisting of sodium thioglycolate, sodium bisulphite, iron salts, glucose and mixtures thereof; the inorganic salts are selected from the group consisting of NaCl, KCl, Na2HPO4, NaH2PO4, KH2PO4, K2HPO4, MgSO4, FeSO4, MnSO4 and mixtures thereof; and the vitamins are selected from the group consisting of biotin, pimelic acid, nicotinamide, calcium pantothenate, folic acid, thiamine nitrate, riboflavin, 4-aminobenzoic acid (PABA) and mixtures thereof.

### Claim 42 (depends on 33)

Culture medium according to claim 33, which is liquid and sterile.

### Claim 43 (depends on 33)

Culture medium according to claim 33, for use in a process for producing Clostridium histolyticum liquid culture supernatant comprising one or more proteases with collagenolytic and gelatinolytic activity.

### Claim 44 (depends on 1)

A process for producing supernatant of Clostridium histolyticum liquid culture comprising one or more proteases with collagenolytic and gelatinolytic activity comprising the following steps:
a) providing a sterile animal product-free culture medium;
b) culturing an aliquot of the Clostridium histolyticum stock culture in the culture medium in step (a), under anaerobic conditions at about 37° C. before reaching the stationary growth phase in order to obtain an inoculum;
c) providing a sterile animal product-free culture medium for Clostridium bacteria according to claim 1;
d) adding to the culture medium in step (c) a volume of inoculum from step (b) equal to or lower than 10% of the final volume of the medium defined in (c);
e) culturing the C. histolyticum obtained in (d) under anaerobic conditions at about 37° C. until the stationary growth phase is attained;
f) removing cellular material and other particulate matter from the liquid phase of the culture in step (e), yielding a supernatant comprising one or more proteases with collagenolytic and gelatinolytic activity.

### Claim 45 (depends on 44)

The process according to claim 44, wherein the step (b) comprising at least the following steps: 1) culturing a stock culture in the medium culture from step (a) in a ratio of 0.1:1 v/v for about 16 hours in order to obtain a pre-inoculum; 2) adding to the pre-inoculum obtained in phase 1 a culture medium volume from stage (a) equal to or higher than the double of the culture medium volume of the from phase (1) and maintaining the culture for about 12 hours in order to obtain an inoculum.

### Claim 46 (depends on 44)

The process according to claim 44, wherein the C. histolyticum culture during the step (e) involves the addition of one or more agents to adjustment pH in sufficient amount to maintain the culture medium pH from 6.5 to 8.0 and wherein the step (f) is carried out through filtration, centrifugation or both.

### Claim 47 (depends on 44)

The process according to claim 44, comprising one or more additional steps for the purification of one or more collagenolytic and gelatinolytic proteases from the supernatant obtained in step (f).

### Claim 48 (depends on 44)

The process according to claim 44, wherein the animal product-free culture medium employed in step (a) comprises water, 0.5% to 5% w/v of vegetable peptone, 0.5% to 5% w/v of yeast extract, 0.01% to 0.1% w/v of cysteine, or its pharmaceutically acceptable salts, and pH between 6.5 and 8.0.

### Claim 49 (depends on 48)

The process according to claim 48, wherein the culture medium comprises water, 3% w/v of vegetable peptone, 3% w/v of yeast extract, 0.0625% w/v of cysteine, or its pharmaceutically acceptable salts, and pH between 6.5 and 8.0.

### Claim 50 (depends on 44)

The process according to claim 44, wherein the animal product-free culture medium employed in step (c) comprises water, 3% w/v of vegetable peptone, 3% w/v of yeast extract, 0.0625% w/v of cysteine, or its pharmaceutically acceptable salts, 0.375% w/v of arginine, or its pharmaceutically acceptable salts, and pH between 7.0 and 8.0.

### Claim 51 (depends on 44)

A supernatant of Clostridium histolyticum liquid culture comprising one or more collagenolytic and gelatinolytic proteases, wherein is produced by the process according to claim 44.

### Claim 52 (depends on 51)

The supernatant according to claim 51, which comprises from 20% to 90% of collagenases after purification.

### Claim 53 (depends on 52)

A pharmaceutical composition comprising as active ingredient the supernatant according to claim 52 and pharmaceutically acceptable excipients, wherein the composition is for topical administration and comprises from 0.2 U to 1.8 U of collagenase per gram of composition.
